Early-stage non-small cell lung cancer (NSCLC) offers a better prognosis than advanced stages. Staging helps inform treatment by describing your cancer's size, lymph node involvement, and metastasis.

Stage 3 non-small cell lung cancer has spread to nearby tissues and lymph nodes but not to more distant tissues. Most people with this stage have lung cancer symptoms. Treatment can depend on several ...

In a trial, selected patients with early non-small cell lung cancer did not benefit from mediastinal lymph node dissection (LND). Mediastinal LND resulted in longer surgeries, increased bleeding, and ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...

NEW ORLEANS — January 31, 2026 — Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for ...

Analysis of a large non-small cell lung cancer (NSCLC) patient cohort with stage IV M1a disease identified lymph node staging as having clinical significance and an impact on prognosis. Lung cancer is ...

Risk Model for Predicting Gaps in Surgical Oncology Care Among Patients With Stage I-III Rectal Cancer From KwaZulu-Natal, South Africa Patients diagnosed with solid-dominant stage I NSCLC between ...

microRNA expression in circulating samples of pancreatic ductal adenocarcinoma patients: A search for circulating biomarkers. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This ...

Metastatic non-small cell lung cancer (NSCLC) occurs when the cancer spreads to other parts of the body, with stage 4 being the most advanced stage. Symptoms of metastatic NSCLC vary depending on ...

Non-small cell lung cancer (NSCLC) has various treatment options, including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, with the selection depending on the cancer’s ...